Jefferies raised the firm’s price target on Coterra Energy (CTRA) to $28 from $26 and keeps a Hold rating on the shares as the firm comes off restriction following the Franklin Mountain/Avant purchase ...
The FDA on Tuesday signed off on Supernus Pharmaceuticals’ apomorphine hydrochloride injection—to be marketed under the brand ...
Palantir stock is trading at a lofty valuation "which history suggests is nearly impossible to grow into," Deutsche Bank's ...
Jefferies analyst Julian Dumoulin-Smith adjusted the price target for PG&E Corporation (NYSE:PCG) stock, reducing it to $20.00 from the previous $25.00, while continuing to recommend the stock as a ...
Oxford, UK - 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the ...
Jefferies maintained a Buy rating on BellRing Brands (NYSE:BRBR) but reduced the price target to $86.00 from the previous $90.00. The company's strong performance is evident in its impressive 21% ...
Jefferies reaffirms 'Buy' on ONGC, citing growth from BP partnership and policy changes. Target price: Rs 375. Read more now.
Among the 23 analysts who follow Palantir, the median target price of $39 per share implies 62% downside from the current ...
Sapiens International (NASDAQ:SPNS – Get Free Report) was downgraded by equities researchers at Jefferies Financial Group from a “buy” rating to a “hold” rating in a report released on Monday, ...
Brighthouse Financial (NASDAQ:BHF – Get Free Report) was downgraded by investment analysts at Jefferies Financial Group from ...
Credit Agricole SA , France's second-biggest listed bank, blew past quarterly earnings forecasts on Wednesday with a 27% jump ...
Amazon is slated to report its fourth-quarter results after the market closes Thursday, with analysts overwhelmingly bullish on the tech titan's stock.